-
Je něco špatně v tomto záznamu ?
The PTH/PTHrP-SIK3 pathway affects skeletogenesis through altered mTOR signaling
F. Csukasi, I. Duran, M. Barad, T. Barta, I. Gudernova, L. Trantirek, JH. Martin, CY. Kuo, J. Woods, H. Lee, DH. Cohn, P. Krejci, D. Krakow,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem
Grantová podpora
R01 AR066124
NIAMS NIH HHS - United States
R01 AR062651
NIAMS NIH HHS - United States
R01 DE019567
NIDCR NIH HHS - United States
NV15-33232A
MZ0
CEP - Centrální evidence projektů
NV15-34405A
MZ0
CEP - Centrální evidence projektů
- MeSH
- HEK293 buňky MeSH
- homozygot MeSH
- intracelulární signální peptidy a proteiny metabolismus MeSH
- lidé MeSH
- missense mutace genetika MeSH
- mTORC1 metabolismus MeSH
- mTORC2 metabolismus MeSH
- mutantní proteiny chemie metabolismus MeSH
- osteogeneze * MeSH
- parathormon metabolismus MeSH
- protein podobný parathormonu metabolismus MeSH
- proteinkinasy chemie nedostatek genetika metabolismus MeSH
- proteolýza MeSH
- růstová ploténka metabolismus MeSH
- sekvence aminokyselin MeSH
- signální transdukce * MeSH
- TOR serin-threoninkinasy metabolismus MeSH
- typy dědičnosti genetika MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Research Support, N.I.H., Extramural MeSH
Studies have suggested a role for the mammalian (or mechanistic) target of rapamycin (mTOR) in skeletal development and homeostasis, yet there is no evidence connecting mTOR with the key signaling pathways that regulate skeletogenesis. We identified a parathyroid hormone (PTH)/PTH-related peptide (PTHrP)-salt-inducible kinase 3 (SIK3)-mTOR signaling cascade essential for skeletogenesis. While investigating a new skeletal dysplasia caused by a homozygous mutation in the catalytic domain of SIK3, we observed decreased activity of mTOR complex 1 (mTORC1) and mTORC2 due to accumulation of DEPTOR, a negative regulator of both mTOR complexes. This SIK3 syndrome shared skeletal features with Jansen metaphyseal chondrodysplasia (JMC), a disorder caused by constitutive activation of the PTH/PTHrP receptor. JMC-derived chondrocytes showed reduced SIK3 activity, elevated DEPTOR, and decreased mTORC1 and mTORC2 activity, indicating a common mechanism of disease. The data demonstrate that SIK3 is an essential positive regulator of mTOR signaling that functions by triggering DEPTOR degradation in response to PTH/PTHrP signaling during skeletogenesis.
Central European Institute of Technology Masaryk University 62500 Brno Czech Republic
Department of Biology Faculty of Medicine Masaryk University 62500 Brno Czech Republic
Department of Orthopaedic Surgery University of California Los Angeles Los Angeles CA 90095 USA
Department of Pediatrics University of California Los Angeles Los Angeles CA 90095 USA
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19045236
- 003
- CZ-PrNML
- 005
- 20201116111830.0
- 007
- ta
- 008
- 200109s2018 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1126/scitranslmed.aat9356 $2 doi
- 035 __
- $a (PubMed)30232230
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Csukasi, Fabiana $u Department of Orthopaedic Surgery, University of California-Los Angeles, Los Angeles, CA 90095, USA.
- 245 14
- $a The PTH/PTHrP-SIK3 pathway affects skeletogenesis through altered mTOR signaling / $c F. Csukasi, I. Duran, M. Barad, T. Barta, I. Gudernova, L. Trantirek, JH. Martin, CY. Kuo, J. Woods, H. Lee, DH. Cohn, P. Krejci, D. Krakow,
- 520 9_
- $a Studies have suggested a role for the mammalian (or mechanistic) target of rapamycin (mTOR) in skeletal development and homeostasis, yet there is no evidence connecting mTOR with the key signaling pathways that regulate skeletogenesis. We identified a parathyroid hormone (PTH)/PTH-related peptide (PTHrP)-salt-inducible kinase 3 (SIK3)-mTOR signaling cascade essential for skeletogenesis. While investigating a new skeletal dysplasia caused by a homozygous mutation in the catalytic domain of SIK3, we observed decreased activity of mTOR complex 1 (mTORC1) and mTORC2 due to accumulation of DEPTOR, a negative regulator of both mTOR complexes. This SIK3 syndrome shared skeletal features with Jansen metaphyseal chondrodysplasia (JMC), a disorder caused by constitutive activation of the PTH/PTHrP receptor. JMC-derived chondrocytes showed reduced SIK3 activity, elevated DEPTOR, and decreased mTORC1 and mTORC2 activity, indicating a common mechanism of disease. The data demonstrate that SIK3 is an essential positive regulator of mTOR signaling that functions by triggering DEPTOR degradation in response to PTH/PTHrP signaling during skeletogenesis.
- 650 _2
- $a sekvence aminokyselin $7 D000595
- 650 _2
- $a růstová ploténka $x metabolismus $7 D006132
- 650 _2
- $a HEK293 buňky $7 D057809
- 650 _2
- $a homozygot $7 D006720
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a typy dědičnosti $x genetika $7 D040582
- 650 _2
- $a intracelulární signální peptidy a proteiny $x metabolismus $7 D047908
- 650 _2
- $a mTORC1 $x metabolismus $7 D000076222
- 650 _2
- $a mTORC2 $x metabolismus $7 D000076225
- 650 _2
- $a mutantní proteiny $x chemie $x metabolismus $7 D050505
- 650 _2
- $a missense mutace $x genetika $7 D020125
- 650 12
- $a osteogeneze $7 D010012
- 650 _2
- $a parathormon $x metabolismus $7 D010281
- 650 _2
- $a protein podobný parathormonu $x metabolismus $7 D044162
- 650 _2
- $a proteinkinasy $x chemie $x nedostatek $x genetika $x metabolismus $7 D011494
- 650 _2
- $a proteolýza $7 D059748
- 650 12
- $a signální transdukce $7 D015398
- 650 _2
- $a TOR serin-threoninkinasy $x metabolismus $7 D058570
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a Research Support, N.I.H., Extramural $7 D052061
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Duran, Ivan $u Department of Orthopaedic Surgery, University of California-Los Angeles, Los Angeles, CA 90095, USA.
- 700 1_
- $a Barad, Maya $u Department of Orthopaedic Surgery, University of California-Los Angeles, Los Angeles, CA 90095, USA.
- 700 1_
- $a Barta, Tomas $u Department of Histology and Embryology, Faculty of Medicine, Masaryk University, 62500 Brno, Czech Republic.
- 700 1_
- $a Gudernova, Iva $u Department of Biology, Faculty of Medicine, Masaryk University, 62500 Brno, Czech Republic.
- 700 1_
- $a Trantirek, Lukas $u Central European Institute of Technology, Masaryk University, 62500 Brno, Czech Republic.
- 700 1_
- $a Martin, Jorge H $u Department of Orthopaedic Surgery, University of California-Los Angeles, Los Angeles, CA 90095, USA.
- 700 1_
- $a Kuo, Caroline Y $u Department of Pediatrics, University of California-Los Angeles, Los Angeles, CA 90095, USA.
- 700 1_
- $a Woods, Jeremy $u Department of Pediatrics, University of California-Los Angeles, Los Angeles, CA 90095, USA.
- 700 1_
- $a Lee, Hane $u Department of Pathology and Laboratory Medicine, University of California-Los Angeles, Los Angeles, CA 90095, USA.
- 700 1_
- $a Cohn, Daniel H $u Department of Orthopaedic Surgery, University of California-Los Angeles, Los Angeles, CA 90095, USA. Orthopaedic Institute for Children, University of California-Los Angeles, Los Angeles, CA 90095, USA. Department of Molecular, Cell and Developmental Biology, University of California-Los Angeles, Los Angeles, CA 90095, USA.
- 700 1_
- $a Krejci, Pavel $u Department of Orthopaedic Surgery, University of California-Los Angeles, Los Angeles, CA 90095, USA. Department of Biology, Faculty of Medicine, Masaryk University, 62500 Brno, Czech Republic. International Clinical Research Center, St. Anne's University Hospital, 65691 Brno, Czech Republic. Institute of Animal Physiology and Genetics of the Czech Academy of Sciences, 60200 Brno, Czech Republic.
- 700 1_
- $a Krakow, Deborah $u Department of Orthopaedic Surgery, University of California-Los Angeles, Los Angeles, CA 90095, USA. dkrakow@mednet.ucla.edu. Orthopaedic Institute for Children, University of California-Los Angeles, Los Angeles, CA 90095, USA. Department of Human Genetics, University of California-Los Angeles, Los Angeles, CA 90095, USA. Department of Obstetrics and Gynecology, University of California-Los Angeles, Los Angeles, CA 90095, USA.
- 773 0_
- $w MED00177505 $t Science translational medicine $x 1946-6242 $g Roč. 10, č. 459 (2018)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30232230 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200109 $b ABA008
- 991 __
- $a 20201116111829 $b ABA008
- 999 __
- $a ok $b bmc $g 1483505 $s 1083909
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 10 $c 459 $e 20180919 $i 1946-6242 $m Science translational medicine $n Sci Transl Med $x MED00177505
- GRA __
- $a R01 AR066124 $p NIAMS NIH HHS $2 United States
- GRA __
- $a R01 AR062651 $p NIAMS NIH HHS $2 United States
- GRA __
- $a R01 DE019567 $p NIDCR NIH HHS $2 United States
- GRA __
- $a NV15-33232A $p MZ0
- GRA __
- $a NV15-34405A $p MZ0
- LZP __
- $a Pubmed-20200109